John A Stalfort III

Director · 2 filings · Latest: Jun 3, 2026

Acumen Pharmaceuticals, Inc.

Taysha Gene Therapies, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ABOS	John A Stalfort III	Director	Jun 3, 2026	Grant/Award	$0.00	35,500	—	220,624	Jun 5 4:30 PM
TSHA	John A Stalfort III	Director	Jun 1, 2026	Grant/Award	$0.00	21,335	—	1,176,559	Jun 2 4:30 PM